sameAs
Nonlinear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG2 (PRO 542) observed in HIV-1-infected childrenAdvances in basic and clinical immunology in 2013Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study GroupEpigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapyMaternal and infant factors associated with failure to thrive in children with vertically transmitted human immunodeficiency virus-1 infection: the prospective, P2C2 human immunodeficiency virus multicenter studyAggregate risk of cardiovascular disease among adolescents perinatally infected with the human immunodeficiency virus.Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts.Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management.Advances in basic and clinical immunology in 2009Molecular virology and immunology of HIV infection.Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.Cardiac biomarkers in HIV-exposed uninfected children.Control lymphocyte subsets: can one country's values serve for another's?Immunoglobulin G kappa [IgG kappa] and IgG lambda paraproteinemia in a child with AIDS and response to highly active antiretroviral therapy.Cardiac status of children infected with human immunodeficiency virus who are receiving long-term combination antiretroviral therapy: results from the Adolescent Master Protocol of the Multicenter Pediatric HIV/AIDS Cohort Study.Transplantation outcomes for severe combined immunodeficiency, 2000-2009.Characteristics of lymphocyte subsets in HIV-infected, long-term nonprogressor, and healthy Asian children through 12 years of ageCord blood banking for potential future transplantation.HIV: clinical manifestations.CD4/CD8 T-cell ratio predicts HIV infection in infants: the National Heart, Lung, and Blood Institute P2C2 Study.Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group.Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothersImmune function during space flight.Immune responses in adult female volunteers during the bed-rest model of spaceflight: antibodies and cytokines.Recognition of clinical immunology as a distinct medical subspecialty: importance for the practice of allergy.Basic and clinical immunology.Trichosporon pullulans infection in 2 patients with chronic granulomatous disease: an emerging pathogen and review of the literature.Decline of CD3-positive T-cell counts by 6 months of age is associated with rapid disease progression in HIV-1--infected infants.Evaluation of coxsackievirus infection in children with human immunodeficiency virus type 1-associated cardiomyopathyCardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study).Increased incidence of asthma in HIV-infected children treated with highly active antiretroviral therapy in the National Institutes of Health Women and Infants Transmission Study.Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioningIncreased risk of asthma and atopic dermatitis in perinatally HIV-infected children and adolescents.Primary immunodeficiency: looking backwards, looking forwards.A 5-week-old HIV-1-exposed girl with failure to thrive and diffuse nodular pulmonary infiltrates.High prevalence of asthma in HIV-infected adults: new insights.Hematopoietic stem cell transplantation for CD3δ deficiency.Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States.Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemia.Advances in asthma, allergy and immunology series 2004: basic and clinical immunology.
P50
Q24679084-8133CDB4-EDD2-436F-9D3A-74BC56FA890CQ27027001-79EF07DA-C183-4CA6-96EA-A0894EBEB2FBQ28239283-80109802-6DAB-4760-BB6F-12F6C0D7E830Q28278011-C7F94BB0-E7EC-4B6B-A2A3-1E4580FEBC8FQ28365722-72302924-2B3F-48A0-B0BF-046AB77A629AQ30576375-AAA75569-DAD0-4C8F-A031-BB7051B44F2DQ33563416-5981925F-B932-4A60-9264-64621F753651Q33700953-D16DED98-91B3-40B0-A919-407A416C7672Q33737600-E5FC6FC1-FB5E-4DF4-93AE-C26210E7E3DDQ33960763-2F3F07AE-CD12-41C4-9FDE-B38E121CE4E9Q33996797-FB9A24FF-7AEB-48A1-8F32-313F5FB5EB4FQ34081675-C8B85E7F-7D84-4C05-8C2A-077F6D90C432Q34112502-5867D1DC-2817-48D4-A47B-2435D34356EFQ34143572-CB4B430E-55DA-47B1-94B6-C83B241874A6Q34269964-5DB5EED4-0B0C-42BC-924F-F86F15A7E4C0Q34279715-61305FE4-C2E1-4FDE-B87D-910C73D65696Q34418680-A7E8AC3A-0479-4531-8933-579881299310Q34597038-4EEF4B75-8C4C-429E-AB93-E029BA2F7E70Q34732172-CA2DE9BC-A0D0-443A-BFF7-C9D2AC22CCCAQ34737680-336E2FAD-299A-4FC9-A1A8-EB1D97A8EC33Q34792820-A33330B2-50B7-4F41-934B-E6EF46A5D12AQ34881120-A668EC16-88FF-4D27-8ED6-DC581719527BQ34934763-42031BE2-DA42-4441-828D-EF2026DEA021Q34949530-2E8795D6-E368-441F-8025-D993DDE3774BQ34954113-BBD5EA3D-CB97-43BB-9D3B-FA6601C34734Q35078596-3D5138D1-E2A8-44B2-9D47-0F3AC9FF0DA7Q35146523-49FE468F-F453-4039-98D5-85DE424AA92CQ35170074-CF9C7221-E43C-41ED-8913-A3103C8FDC1EQ35578679-404324E7-F414-4770-B0C1-0BB246467047Q35626381-D77EEC2E-D33F-4567-82AA-197D44B4F356Q35634803-09020C02-DA0B-42D7-9214-F4EE0B37768BQ35728637-4D6220BA-72D6-4B48-8BC9-155ED376B4A8Q35740081-481000E1-9207-4EB6-9EEF-82714C76BD4EQ35752382-4B16E66A-34D1-4E57-B56D-3B16AA398068Q35752394-F0B4596F-7688-4AE9-B16F-C915B4016308Q35803215-9E2B8010-7E30-4906-A6E4-A479B8BAC564Q35815147-ACB4D7CB-E0AF-4A5E-9273-6D7F80D8EC8DQ35820252-1FB6182F-4D02-42EB-9E43-DB1AE1AC02A2Q35848108-D8FC2059-5522-4E7B-A57D-783787F5F527Q35865745-CB75A1E2-48F2-4765-87CB-92D5D71D726D
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
William T. Shearer
@ast
William T. Shearer
@en
William T. Shearer
@es
William T. Shearer
@it
William T. Shearer
@nl
William T. Shearer
@sl
ويليام شيرر
@ar
type
label
William T. Shearer
@ast
William T. Shearer
@en
William T. Shearer
@es
William T. Shearer
@it
William T. Shearer
@nl
William T. Shearer
@sl
ويليام شيرر
@ar
altLabel
William Shearer
@ast
William Shearer
@en
William Shearer
@es
William Shearer
@it
William Shearer
@nl
prefLabel
William T. Shearer
@ast
William T. Shearer
@en
William T. Shearer
@es
William T. Shearer
@it
William T. Shearer
@nl
William T. Shearer
@sl
ويليام شيرر
@ar
P1006
P214
P244
P1006
P1153
55049801300
P1412
P21
P213
0000 0000 3782 1591
P214
P244
n2002158906
P31
P496
0000-0002-2483-2130
P569
1937-08-23T00:00:00Z
P570
2018-10-09T00:00:00Z
P7859
lccn-n2002158906